Dr. Priya Tarun Mehta, MD

Dr. Mehta practices at Chestnut Hill Allergy And Asthma Associates in Glenside, Pennsylvania.

Dr. Mehta's NPI, 1851741532, was assigned on June 14, 2016. Dr. Mehta graduated from George Washington University School of Medicine and Health Sciences in 2016. Dr. Mehta holds Pennsylvania license MD467679.

Dr. Mehta's primary practice is Chestnut Hill Allergy and Asthma Associates, at 8200 Flourtown Ave Suite 4 Suite 4, Glenside, PA 19038-7969. The practice phone is (215) 247-2292.

Dr. Mehta's primary practice is Chestnut Hill Allergy And Asthma Associates in Glenside, Pennsylvania. The medical group on file is Chestnut Hill Allergy & Asthma Associates, LLC.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Mehta is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Mehta is licensed in Pennsylvania.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives and upper respiratory infection (URI) among the conditions Dr. Mehta treats.

CMS data shows 3,172 Medicare services from Dr. Mehta across 10 procedure codes in 2024, for 171 Medicare patients. Medicare paid $46,845 for them. Every service was in an office.

CMS counts 171 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 8% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 32, with 60% women.

In 2024, Dr. Mehta wrote 374 Medicare Part D claims for 85 patients. 67% of them were for generic drugs. CMS names the drug for 258 of them, across 9 drugs with 11 or more claims each, at $26,047 in total drug cost. In 2023, CMS named 206 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Mehta for performance year 2024, reported as part of a group. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth.

Dmand AI links 2 papers to Dr. Mehta, published from 2017 to 2020. Dr. Mehta has published most often in Ann Allergy Asthma Immunol. Dr. Mehta's most frequent co-authors are Magee L. Defelice, MD, Christine Anne Malloy, MD and Hemant Prashad Sharma, MD.

CMS Open Payments shows 144 general payments to Dr. Mehta from 14 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Genentech, Inc. paid the most, $14,861.

Dr. Mehta graduated from George Washington University School of Medicine and Health Sciences in 2016.

Dr. Mehta is in network with 18 carriers, including Aetna, HCSC and Highmark. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.